1. Kuznetsov NI, Romanov ES, Startseva GYu. Modern principles of anti-viral therapy of hepatitis C. Russian Family Doctor. 2018;22(3):23–27. (In Russ.). https://doi.org/10.17816/RFD2018323-27
2. Arisheva OS, Moiseev SV, Kotenko ON. Daclatasvir and asunaprevir combination in hemodialysis patients with chronic hepatitis C. Clin Pharmacol Ther. 2016,25(3):5–10. (In Russ.).
3. Akimkin VG, Semenenko TA, Nikitina GYu, Godkov MA, Skvortsov SV. Epidemiology of hepatitis B and C in treatment and prophylactic institutions. Moscow: Bionics Publ.; 2013. (In Russ.).
4. Milovanova SYu, Milovanov YuS, Kozlovskaya LV, Komyagin YuV. Profilaktika i lecheniye virusnykh gepatitov B i C u bolnykh na programmnom gemodialize. Gepatologicheskiy forum. 2009;(4):19–26. (In Russ.).
5. Yarosh LV, Semenenko TA, Nikitina GYu, Shutov EV, Elgort DA, Feldsherova AA, et al. Prevalence of the hepatitis B and C viruses markers in the hemodialysis departments. Nephrology and dialysis. 2013;15(4):293–298. (In Russ.).